Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off 
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
Instagram Outage Disrupts Thousands of U.S. Users 
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Naver Cloud became the first South Korean cloud service provider to develop a gene data analysis platform.
The newly-developed Nvidia Clara Parabricks on the platform of Naver Cloud, an affiliate of South Korea’s leading internet portal operator Naver Corp., is the combination of the Naver Cloud server with US graphics chip giant Nvidia Corp.’s Clara Parabricks software suite.
Clara Parabricks is a system that uses huge graphic processing units to interpret gene data.
Naver Cloud plans to launch the Genome Analysis All-in-One Integrated Platform in its marketplace in the first half of this year, in conjunction with local personal genomics business ichrogene.
Beginning with the cooperation with Nvidia and ichrogene, Naver Cloud will continue to expand its presence in the gene analysis market, according to the company’s executive director, Han Sang-young.
